Gene therapy versus cochlear implants for congenital hearing loss
Part of Brain & nervous system, Ear, nose & throat, Genetic & congenital clinical trials.
This study looks at how well gene therapy or cochlear implants help restore hearing in people with severe hearing loss from birth. It compares the outcomes of these two treatments to see which is more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Patient must be at least 6 months old
- Hearing loss must be present from birth
- Hearing loss must be severe (threshold of 70 dB or more)
- Patient must either already have had gene therapy or be scheduled for it, or have a cochlear implant
- Patient must be a native Mandarin speaker
- A legal guardian must sign a consent form
- Patient must be able to attend follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is developing a system to evaluate and improve hearing for people with congenital hearing loss. It compares participants who have hearing loss (and have used hearing aids, cochlear implants, or gene therapy) with healthy controls, to better understand and treat hearing challenges.
This study follows people who get a cochlear implant – a device that helps restore hearing. It tracks how well you hear over time and checks for any long-term benefits or problems.
This study checks whether cochlear implants help young children (ages about 7 months to under 3 years) who have very severe hearing loss in one ear. It also compares them with similar children who do not get implants, to understand what outcomes to expect.
This trial tests a program to help adults who use a cochlear implant hear better, especially those who have hearing loss in only one ear or who are getting a second implant. It aims to optimize hearing performance after the implant is activated.
This trial looks at how hearing with both ears helps children with cochlear implants listen more easily and think better. It compares kids with implants to those with normal hearing.
This study follows children with hearing loss caused by changes in specific genes (GJB2 or OTOF). It helps researchers understand how hearing develops over time and how children may do with or without cochlear implants.
Hear when a new Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.